Outset Medical Inc (OM) Stock Price, Quote & News

Company Profile

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing p...

Industry: Medical Devices

Sector: Healthcare

Phone: 669 231 8200

Website: www.outsetmedical.com

Address:

3052 Orchard Drive, San Jose, United States

ShaunmanO May. 12 at 4:39 PM

$OM beautiful retrace. Let's go back to pre-ER and beyond. See? Told y'all the ER was not bad. Penny pinching panickers.

1 · Reply

Technicalcharter May. 11 at 3:17 PM

$OM chart is not good but I can see it tracing back 4.18 even if there is further downside. I can see buyers waiting every day for it to fall before they load. That’s smart but we need a big catalyst

0 · Reply

SEACAI May. 11 at 7:51 AM

$OM I thought that Vanguard dropped off because they did not file the 13G. They have filed now the 13F and they still maintain 982K shares in OM for a 5.35% holding of all shares outstanding. They was through multiple vehicles of Vanguard. A good sign. Institutional holding is currently showing being at 96% as at 31 March. This is one of the highest institutional holdings in my portfolio. In other news, 72% were shorted on Friday leading to the big drop. At least it was not driven by actual sales 😀. The only problem for shorters now, is that they have to buy back the shares to close the position and make money. Good luck.

0 · Reply

SEACAI May. 9 at 9:26 AM

$OM @giu_ve that is a good way to look at it. Revenues thresholds that you outlined are very doable, so I look forward to them achieving them. I’ll also look for cash burn, and clues about the pipeline (including closing the deals that shifted from Q1). I also want them to confirm that Tablo 2.0 has gone out the door to customers in Q2. I am also curious about earnings traction of EMR as an add on revenue item and the true EMR demand by customers. All these would confirm the thesis.

1 · Reply

giu_ve May. 9 at 7:55 AM

$OM Yesterday was brutal for me. This happens when you own a boat load of shares and the SP goes south more than 20%. Nevertheless, I slept well and might add some shares to my holding. Management has two more quarters to prove that whatever they say is not BS. I am expecting revenues up for the second quarter (bare minimum 29 millions, would prefer 30) and at least 33 millions for the 3rd. No more BS.....

0 · Reply

giu_ve May. 9 at 7:55 AM

0 · Reply

MarketBeat May. 8 at 8:03 PM

Outset Medical Q1 Earnings Call Highlights $OM #OutsetMedical #instantalerts #NASDAQ:OM https://www.marketbeat.com/instant-alerts/outset-me

0 · Reply

Nilsholgerson May. 8 at 7:05 PM

$OM shareholders should be requesting management to disclose these redacted numbers

1 · Reply

SEACAI May. 8 at 6:18 PM

$OM price to sales is .5 and P/BV is .67. CRAZY STUFF. Add to that historic high product gross margin and the $161 in cash. The short of it, know what you own and have some patience. We all want the SP to go up, and it will. This is a multibagger, but it still needs some time. I’ve entered in November and I’m in it for 2-3 years.

1 · Reply

Technicalcharter May. 8 at 3:22 PM

$OM with this stock price; cash - debt = market cap; which means as of now their business has zero value which obviously is a rediculous argument. I can understand it cannon be a $11 stock (which is my target) today but this valuation is incredibly undervalued. So far fall is stock is not meeting same volume. We will see what happens rest of the day and next week.

0 · Reply

Outset Medical to Present at RBC Global Healthcare Conference

2026-05-08T19:39:37.000Z - 4 days ago

Outset Medical price target lowered to $10 from $12 at TD Cowen

2026-05-08T12:49:46.000Z - 4 days ago

Outset Medical price target lowered to $6 from $8 at Stifel

2026-05-07T20:50:00.000Z - 5 days ago

Outset Medical reports Q1 EPS ($1.03), consensus (79c)

2026-05-07T20:48:47.000Z - 5 days ago

Outset Medical backs FY26 revenue view $125M-$130M, consensus $126.77M

May 7, 2026, 4:30 PM EDT - 5 days ago

Outset Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 4:02 PM EDT - 5 days ago

Outset Medical Reports First-Quarter Results

Apr 27, 2026, 4:05 PM EDT - 15 days ago

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Apr 13, 2026, 12:15 PM EDT - 4 weeks ago

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Apr 8, 2026, 4:05 PM EDT - 4 weeks ago

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 6, 2026, 4:05 PM EDT - 5 weeks ago

Outset Medical Names Derick Elliott as Executive Vice President of Commercial

2026-02-12T13:45:28.000Z - 3 months ago

Outset Medical price target lowered to $12 from $15 at TD Cowen

2026-02-12T12:41:06.000Z - 3 months ago

Outset Medical price target lowered to $15 from $17 at BTIG

Feb 11, 2026, 4:30 PM EST - 3 months ago

Outset Medical Earnings Call Transcript: Q4 2025

2026-02-11T21:11:53.000Z - 3 months ago

Outset Medical reports Q4 EPS ($1.09), consensus (68c)

2026-02-11T21:10:45.000Z - 3 months ago

Outset Medical sees FY26 revenue $125M-$130M, consensus $127.64M

Feb 11, 2026, 4:02 PM EST - 3 months ago

Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results

2026-01-27T14:12:32.000Z - 3 months ago

Outset Medical says next-generation Tablo platform receives FDA clearance

Jan 27, 2026, 9:00 AM EST - 3 months ago

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Jan 26, 2026, 4:05 PM EST - 3 months ago

Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026

Jan 14, 2026, 7:30 PM EST - 4 months ago

Outset Medical Transcript: 44th Annual J.P. Morgan Healthcare Conference

2026-01-12T13:50:48.000Z - 4 months ago

Outset Medical reports Q4 revenue $28.9M, consensus $26.15M

2026-01-12T13:50:24.000Z - 4 months ago

Outset Medical appoints Prange to its board of directors

ATRC

Jan 12, 2026, 8:30 AM EST - 4 months ago

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

2026-01-07T12:41:25.000Z - 4 months ago

Outset Medical price target lowered to $8 from $14 at Stifel

Jan 5, 2026, 4:05 PM EST - 4 months ago

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

2025-12-17T13:55:43.000Z - 5 months ago

Outset Medical price target lowered to $7 from $17 at RBC Capital

2025-12-03T18:45:20.000Z - 5 months ago

Outset Medical management to meet virtually with BTIG

Nov 12, 2025, 10:40 AM EST - 6 months ago

Outset Medical Transcript: Stifel 2025 Healthcare Conference

2025-11-11T14:20:20.000Z - 6 months ago

Outset Medical price target lowered to $17 from $22 at RBC Capital

2025-11-11T12:55:20.000Z - 6 months ago

Outset Medical price target lowered to $15 from $25 at TD Cowen

2025-11-11T12:45:14.000Z - 6 months ago

Outset Medical price target lowered to $14 from $17 at Stifel

2025-11-11T12:20:36.000Z - 6 months ago

Outset Medical price target lowered to $17 from $39 at BTIG

2025-11-10T21:35:58.000Z - 6 months ago

Outset Medical reports Q3 EPS ($1.00), consensus (65c)

2025-11-10T21:35:28.000Z - 6 months ago

Outset Medical lowers FY25 revenue outlook to $115M-$120M from $122M-$126M

Nov 10, 2025, 4:30 PM EST - 6 months ago

Outset Medical Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:05 PM EST - 6 months ago

Outset Medical Reports Third-Quarter Results

Nov 5, 2025, 4:05 PM EST - 6 months ago

New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo® Hemodialysis System

Nov 5, 2025, 9:00 AM EST - 6 months ago

Outset Medical to Present at the 2025 Stifel Healthcare Conference

Oct 27, 2025, 4:05 PM EDT - 7 months ago

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Sep 10, 2025, 7:00 AM EDT - 8 months ago

Outset Medical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 9:00 AM EDT - 8 months ago

Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis

Aug 20, 2025, 4:05 PM EDT - 9 months ago

Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference

Aug 6, 2025, 5:00 PM EDT - 9 months ago

Outset Medical Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:02 PM EDT - 9 months ago

Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization

Jul 30, 2025, 9:01 AM EDT - 10 months ago

Outset Medical Names First Chief Nursing Officer

Jul 16, 2025, 4:03 PM EDT - 10 months ago

Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

Jun 11, 2025, 11:20 AM EDT - 11 months ago

Outset Medical Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 5, 2025, 9:05 AM EDT - 1 year ago

Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Jun 3, 2025, 4:30 PM EDT - 1 year ago

Outset Medical Appoints Renee Gaeta as Chief Financial Officer

Jun 2, 2025, 1:30 PM EDT - 1 year ago

Outset Medical Transcript: AGM 2025

May 20, 2025, 10:30 AM EDT - 1 year ago

Outset Medical Transcript: RBC Capital Markets Global Healthcare Conference 2025

May 14, 2025, 9:00 AM EDT - 1 year ago

Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors

May 7, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Earnings Call Transcript: Q1 2025

May 7, 2025, 4:02 PM EDT - 1 year ago

Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined

Mar 18, 2025, 8:30 AM EDT - 1 year ago

Outset Medical Announces One-for-Fifteen Reverse Stock Split

Feb 24, 2025, 4:03 PM EST - 1 year ago

Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference

Feb 19, 2025, 5:00 PM EST - 1 year ago

Outset Medical Earnings Call Transcript: Q4 2024

Feb 19, 2025, 4:03 PM EST - 1 year ago

Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 13, 2025, 4:35 PM EST - 1 year ago

Outset Medical Announces Resolution of Warning Letter

Feb 6, 2025, 5:52 PM EST - 1 year ago

Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm

Feb 3, 2025, 9:00 AM EST - 1 year ago

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

Jan 15, 2025, 11:15 AM EST - 1 year ago

Outset Medical Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 6, 2025, 8:30 AM EST - 1 year ago

Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors

Nov 19, 2024, 10:20 AM EST - 1 year ago

Outset Medical Transcript: Stifel 2024 Healthcare Conference

Nov 15, 2024, 9:00 AM EST - 1 year ago

Outset Medical to Present at the 2024 Stifel Healthcare Conference

Nov 6, 2024, 5:00 PM EST - 1 year ago

Outset Medical Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:02 PM EST - 1 year ago

Outset Medical Reports Third Quarter 2024 Financial Results

Oct 23, 2024, 4:05 PM EDT - 1 year ago

New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo

Oct 23, 2024, 9:00 AM EDT - 1 year ago

Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024

ShaunmanO May. 12 at 4:39 PM

$OM beautiful retrace. Let's go back to pre-ER and beyond. See? Told y'all the ER was not bad. Penny pinching panickers.

1 · Reply

Technicalcharter May. 11 at 3:17 PM

0 · Reply

SEACAI May. 11 at 7:51 AM

0 · Reply

SEACAI May. 9 at 9:26 AM

1 · Reply

giu_ve May. 9 at 7:55 AM

0 · Reply

giu_ve May. 9 at 7:55 AM

0 · Reply

MarketBeat May. 8 at 8:03 PM

Outset Medical Q1 Earnings Call Highlights $OM #OutsetMedical #instantalerts #NASDAQ:OM https://www.marketbeat.com/instant-alerts/outset-me

0 · Reply

Nilsholgerson May. 8 at 7:05 PM

$OM shareholders should be requesting management to disclose these redacted numbers

1 · Reply

SEACAI May. 8 at 6:18 PM

1 · Reply

Technicalcharter May. 8 at 3:22 PM

0 · Reply

ShaunmanO May. 8 at 1:47 PM

$OM I don't understand people freaking out over an ER that basically said "yeah we didn't make QUITE as much revenue this quarter but we were far more profitable on what we made". The guidance was good. I think it will bounce once the panickers are out and people realize the positives.

1 · Reply

giu_ve May. 8 at 1:38 PM

$OM very low volume even today. The funny part of this 4$ stock is that you can drop SP by almost a dollar with only 13k shares traded. It took 2 months and more to rise from 3 to 4.5.....

0 · Reply

SEACAI May. 8 at 12:37 PM

$OM the overall trajectory is positive. Capital sales is “lumpy”, this is a fact. And it applies to all Medtech who go through the capital sales processes. The good news is that we appear to be at the tail end of that. Two sentences stood out for me in the call regarding internalizing Tablo: 1. “Here in the second quarter, our team is replicating this success with go-live implementations occurring at more than 30 facilities involving nearly 200 consoles.” THIS IS BIG. And 2 “a few weeks ago in Texas. Over the course of 2 days, our team set up dialysis service lines at multiple hospitals owned by one of the largest health systems in the country. These facilities had a total of approximately 400 beds. Add this to Multicare in WA and OR in the past few weeks that I shared earlier and the service engineer hiring spree. I think Q2 is solid and will lead to a very good Q3 and Q4. Btw, I do appreciate their lack of overhype, just facts.

0 · Reply

MikeyNJ May. 8 at 12:07 PM

$OM At this point, it's a long term call option on a potential turnaround story.

1 · Reply

Nilsholgerson May. 8 at 6:36 AM

$OM tablo does not sell - simple

1 · Reply

shym10 May. 7 at 11:32 PM

$OM still very bullish longterm!

0 · Reply

Technicalcharter May. 7 at 9:41 PM

$OM this can go down as much as it can but $161M in cash and market cap less than half of it? I think market expected this that is why it didn’t really go up much. I can understand stocks which are overhyped fall big time with ok results but this one; hard to believe but I will see what market brings tomorrow and yes if it goes below $3; I will buy significant chunk.

1 · Reply

ctpo2002 May. 7 at 9:36 PM

$OM The results were absolutely dismal, where it missed the consensus for Q1, hinted that it will not likely meet the consensus for Q2, and a lot of uncertainly at this point whether they will be able to really ramp up in Q3 and Q4. It only takes one sentence in a press release to lower the FY guidance. There were only 2 analysts in the CC, compared to 4 historically, so it shows they are losing interest in this company. It will be a bloodbath tomorrow, where the funds and institutions will be dumping. I wouldn't be surprised if it goes back down to $3OR lower. If you have not voted for the shareholder meeting next month, vote down their compensation proposal. I certainly did..good luck to all.

1 · Reply

StocktwitsEarnings May. 7 at 9:32 PM

$OM Q1 '26 Earnings Results & Recap Outset Medical reported total revenue of $27.9M for Q1 2026, a 6% decrease from the prior year, with product revenue down 13% and service revenue up 10%. The company's gross margin improved to 43.4%.

0 · Reply

SEACAI May. 7 at 9:12 PM

$OM overall, the results and the call were inline with my expectations. As mentioned previously, the third quarter is key. The pipeline sounds robust, but they need to close those deals. Guidance was affirmed, which is good despite the “lumpiness “ of the capital sales. The biggest positive news is the $12 mn usage of cash in Q1 , which is lower than expected and the forecast of using less than $40 mn in cash for the whole year. They currently have $161 mn of cash which is a bit under 200% of the current market cap!!!and the debt is about $97 mn and is due in 2030.

4 · Reply

giu_ve May. 7 at 5:26 PM

$OM what do we think guys:

1 · Reply

SEACAI May. 6 at 3:32 PM

$OM To continue with the theme of accumulation, UBS has added 245% to their original position and now own 252k shares of OM in Q1 2026. They now own 1.5% of total shares outstanding of Outset Medical. A true blue chip investor seeing the huge value in OM.

1 · Reply

Market Cap	67.66M
Revenue (ttm)	119.48M
Net Income (ttm)	-81.65M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-68.34%
Debt to Equity Ratio	0.87

Volume	186,600
Avg Vol	167,178
Day's Range	N/A - N/A
Shares Out	18.54M
Stochastic %K	27%
Beta	1.92
Analysts	Sell
Price Target	$8.33